Bio Law Blog

Insights into IP and regulatory developments for biologic medicines.
Subscribe here for automatic updates to your inbox.

  • Welcome to the Bio Law Blog. Our blog shares insights into intellectual property law for biologic medicines and related regulatory and legislative developments. We started this blog to engage in a conversation about the rapidly developing U.S. biosimilars pathway (the Biologics Price Competition and Innovation Act) and the recent surge in approvals for cutting-edge biologic products, such as siRNAs and cell-based and gene therapies. These new biologic products are changing medicine and posing new intellectual property questions and challenges. We also analyze developments in written description and enablement law for antibodies, the impact of Section 101 on biotech discoveries, and the increasing role of the Patent Trial and Appeal Board in reviewing biotech patents. We share a perspective as trial lawyers immersed in biology and biotech patent law.

    We are excited to be part of these transformative times for biologic medicines and to discuss them with you. We hope you enjoy our blog, and we welcome any questions, comments or suggestions.

    Subscribe for updates here.

    Featured Posts

    • Bio Law Blog
      Jan. 19, 2024
      Law360: Supreme Court Amgen Ruling's Major Effect On Enablement
      Read More
    Show Filters

    Recent Posts

    • Bio Law Blog
      Jan. 19, 2024
      Law360: Supreme Court Amgen Ruling's Major Effect On Enablement
      Read More
    • Bio Law Blog
      Sept. 19, 2023
      10x Genomics and Stanford’s Genomic Patents Determined Patent Eligible
      Read More
    • Bio Law Blog
      Nov. 23, 2021
      Northern District of California Dismisses Challenge to PTAB’s Fintiv Factors
      Read More
    • Bio Law Blog
      Nov. 16, 2021
      ChromaDex Milk Vitamin Formulation Patents Soured by Section 101
      Read More
    • Bio Law Blog
      Nov. 09, 2021
      United States Calls for Supreme Court to Deny Petition for Certiorari Challenging Fintiv Factors
      Read More
    • Bio Law Blog
      Sept. 22, 2021
      Northern District of Illinois Holds That a Biosimilar Applicant Is Not a Necessary Party to a BPCIA Lawsuit
      Read More

    Featured Perspectives

    • Articles
      July 28, 2021
      Life Sciences Patent Owners Face a Transformed Inter Partes Review Environment at the USPTO
      Read More
    • Announcements
      July 28, 2021
      Hannah Lee Named to Daily Journal's 2021 Top 40 Under 40 List
      Read More
    • Announcements
      July 28, 2021
      Lisa Kobialka Named to Managing IP's 2021 Top 250 Women in IP List
      Read More
    • Announcements
      July 21, 2021
      Hannah Lee Named to Benchmark Litigation’s 2021 40 & Under Hot List
      Read More
    • Announcements
      June 01, 2021
      Hannah Lee, Josh Winefsky Named Law360 Rising Stars
      Read More

    Editors

  • People

  • Perspectives

    See Related Results In:

    Perspectives

    • Media Mentions
      Feb. 02, 2024
      Kramer Levin Centripetal Trial Team Named “Runners-up” in Litigation Daily’s Litigator of the Week
      Read More
    • Defining Matters
      Feb. 01, 2024
      Kramer Levin Secures $151.5M Judgment for Centripetal in Cybersecurity Patent Case
      Read More
    • Articles
      Jan. 16, 2024
      Supreme Court Amgen Ruling's Major Effect On Enablement
      Read More
    • Articles
      Jan. 03, 2024
      Netflix’s ‘Black Mirror’ Shows AI’s Perils With Lax Legal Rules
      Read More
    • Client Alerts
      Dec. 05, 2023
      AI Policies
      Read More
    • Announcements
      Dec. 04, 2023
      Kramer Levin Elevates Three Lawyers to Partner
      Read More
    • Announcements
      Oct. 18, 2023
      Benchmark Litigation 2024 Recognizes Kramer Levin
      Read More
    • Articles
      Oct. 17, 2023
      How 2nd Circ. Clarified A Key Right Of Publicity Claim Issue
      Read More
    • Announcements
      Sept. 22, 2023
      2023 New York Super Lawyers and Rising Stars Lists Include Over 90 Kramer Levin Attorneys
      Read More

    Events

    • Speaking Engagement
      March 20, 2024
      American Conference Institute’s 2nd Annual Forum on IP, Funding and Tech Strategies for Novel Therapeutic Modalities
      Read More
    • Speaking Engagement
      Nov. 01, 2023
      Centerforce’s IP Strategy Summit - 2023
      Read More
    • Speaking Engagement
      Oct. 26, 2023
      CenterForce’s Diversity In IP & Tech Summit
      Read More
    • Speaking Engagement
      Oct. 25, 2023
      Centerforce’s IP Strategy Summit
      Read More
    • Sponsorship
      Sept. 10, 2023
      Intellectual Property Owners Association’s 2023 Annual Meeting
      Read More
    • Speaking Engagement
      June 27, 2023
      American Conference Institute’s Biosimilars & Innovator Biologics 2023
      Read More
    • Sponsorship
      June 09, 2023
      New Jersey Intellectual Property Law Association’s 2023 Jefferson Medal Dinner
      Read More
    • Speaking Engagement
      June 08, 2023
      American Council on Germany’s AI: Transatlantic Business and Policy Implications
      Read More
    • Speaking Engagement
      June 01, 2023
      International Bar Association’s 9th Annual IBA World Life Sciences Conference
      Read More

Connect with us.

Subscribe here

Related Practices

We use cookies on this website to optimize user experience and site functionality and to give you the best possible experience. We do so with your approval. The choice is up to you. Learn more.